These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 18640950)

  • 21. Aromatase inhibitors as adjuvant therapy for breast cancer.
    Montemurro F; Aglietta M; Del Mastro L
    J Clin Oncol; 2009 May; 27(15):2566-7. PubMed ID: 19332706
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemotherapy--overview and future perspectives.
    Aebi S
    Breast; 2006 Dec; 15 Suppl 2():S11-4. PubMed ID: 17382854
    [No Abstract]   [Full Text] [Related]  

  • 23. On the way to specifically targeting minimal residual disease?
    Gebauer G
    Breast Cancer Res; 2008; 10(5):112. PubMed ID: 18947365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer in the elderly.
    Thomas GA; Leonard RC
    Clin Oncol (R Coll Radiol); 2009 Mar; 21(2):79-80. PubMed ID: 19071001
    [No Abstract]   [Full Text] [Related]  

  • 25. Circulating epithelial cells in breast cancer.
    Tang C; Lin AY
    N Engl J Med; 2004 Dec; 351(23):2452-4; author reply 2452-4. PubMed ID: 15580681
    [No Abstract]   [Full Text] [Related]  

  • 26. Systemic therapy for early breast cancer.
    Hargis JB; Jain D
    J Ky Med Assoc; 2009 Oct; 107(10):401-6. PubMed ID: 19873798
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of breast cancer metastasis by dual liposomes to disturb complex formation.
    Wenzel J; Zeisig R; Fichtner I
    Int J Pharm; 2009 Mar; 370(1-2):121-8. PubMed ID: 19100823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assays that predict outcomes make slow progress toward prime time.
    Schmidt C
    J Natl Cancer Inst; 2010 May; 102(10):677-9. PubMed ID: 20460635
    [No Abstract]   [Full Text] [Related]  

  • 29. Circulating tumor cell count could be used to determine treatment of metastatic breast cancer.
    Printz C
    Cancer; 2019 Apr; 125(7):1021. PubMed ID: 30875105
    [No Abstract]   [Full Text] [Related]  

  • 30. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
    Tanei T; Morimoto K; Shimazu K; Kim SJ; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2009 Jun; 15(12):4234-41. PubMed ID: 19509181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant anthracyclines and taxanes: quantifying the costs of therapeutic advances in breast cancer.
    Morris PG; Bach PB
    Onkologie; 2009 Sep; 32(8-9):464-6. PubMed ID: 19745589
    [No Abstract]   [Full Text] [Related]  

  • 32. Circulating tumor cells in metastatic breast cancer: timing of blood extraction for analysis.
    Martín M; García-Sáenz JA; Maestro De las Casas ML; Vidaurreta M; Puente J; Veganzones S; Rodríguez-Lajusticia L; De la Orden V; Oliva B; De la Torre JC; López-Tarruella S; Casado A; Sastre J; Díaz-Rubio E
    Anticancer Res; 2009 Oct; 29(10):4185-7. PubMed ID: 19846970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of toxicity and toxicity profile of adjuvant chemotherapy in elderly breast cancer patients.
    Garg P; Rana F; Gupta R; Buzaianu EM; Guthrie TH
    Breast J; 2009; 15(4):404-8. PubMed ID: 19508671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonhormonal systemic therapy for advanced breast cancer: do the math!
    Bedard PL; Piccart-Gebhart MJ
    J Natl Cancer Inst; 2008 Dec; 100(24):1745-7. PubMed ID: 19066269
    [No Abstract]   [Full Text] [Related]  

  • 35. Anatomy of the breast.
    Spratt JS
    Major Probl Clin Surg; 1979; 5():1-13. PubMed ID: 459554
    [No Abstract]   [Full Text] [Related]  

  • 36. Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.
    Apostolaki S; Perraki M; Kallergi G; Kafousi M; Papadopoulos S; Kotsakis A; Pallis A; Xenidis N; Kalmanti L; Kalbakis K; Agelaki S; Kalykaki A; Stournaras C; Stathopoulos E; Georgoulias V; Mavroudis D
    Breast Cancer Res Treat; 2009 Oct; 117(3):525-34. PubMed ID: 19016323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Commentary: anthracyclines in early-stage breast cancer: is it the end of an era?
    Pritchard KI
    Oncologist; 2009 Oct; 14(10):959-62. PubMed ID: 19819915
    [No Abstract]   [Full Text] [Related]  

  • 38. [New period of systemic treatment for breast cancer].
    Hamaoka T
    Gan To Kagaku Ryoho; 2008 Sep; 35(9):1457-60. PubMed ID: 18799897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system?
    Dawood S; Broglio K; Valero V; Reuben J; Handy B; Islam R; Jackson S; Hortobagyi GN; Fritsche H; Cristofanilli M
    Cancer; 2008 Nov; 113(9):2422-30. PubMed ID: 18785255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The detection of circulating tumor cells of breast cancer patients by using multimarker (Survivin, hTERT and hMAM) quantitative real-time PCR.
    Shen C; Hu L; Xia L; Li Y
    Clin Biochem; 2009 Feb; 42(3):194-200. PubMed ID: 19022237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.